Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
Works of Thomas Evers being referenced
Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes
2022
Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas Evers | 615 | 140 | 102 | 152 | 56 | 970 | |
| Gang Fang | 401 | 210 | 107 | 112 | 38 | 935 | |
| Erin R. Weeda | 213 | 74 | 85 | 149 | 80 | 858 | |
| Joel I. Reisman | 625 | 105 | 55 | 268 | 63 | 1.1k | |
| Hernan Polo Friz | 475 | 38 | 153 | 180 | 42 | 874 | |
| Shun Fu Lee | 390 | 80 | 141 | 42 | 46 | 806 | |
| Karin A. H. Kaasjager | 378 | 44 | 171 | 179 | 69 | 1.1k | |
| Li Wang | 275 | 63 | 180 | 139 | 73 | 1.1k | |
| Marjorie E. Zettler | 499 | 119 | 231 | 84 | 63 | 1.1k | |
| Vinit Nair | 195 | 180 | 70 | 109 | 32 | 871 | |
| Erik Youngson | 517 | 148 | 138 | 36 | 68 | 943 |
All Works
Login with ORCID to disown or claim papers
Loading papers...